期刊文献+

内镜下氩离子凝固术加埃索美拉唑治疗舌型及岛型短段Barrett’s食管的临床研究

Clinical study of endoscopic argon plasma coagulation combined with esomeprazole using for island-type and tongue-type SSBE
暂未订购
导出
摘要 目的探讨内镜下氩离子凝固术(APC)加埃索美拉唑治疗舌型及岛型SSBE疗效及安全性。方法内镜及病理检查确诊为舌型或岛型的SSBE患者45例随机分为两组,治疗组24例行内镜下APC加埃索美拉唑治疗,对照组21例单纯给予口服埃索美拉唑治疗,分别于治疗后3,6,9及12个月复查胃镜并取活检送病理检查。治疗组中复查胃镜未达显效的患者,再行镜下APC治疗并继续口服埃索美拉唑治疗4周。结果治疗组患者治疗后3,6,9及12个月总有效率均为100%,平均显效率为87.5%,与对照组(30.5%,6.1%)相比较,差异具有显著性(P<0.01);治疗组未出现出血、穿孔、食管狭窄等相关并发症。结论内镜下APC联合埃索美拉唑治疗SSBE疗程短,安全有效,并发症少。 [Objective] To study the clinical effects of endoscopic argon plasma coagulation(APC) combined with esomeprazole using for island-type and tongue-type SSBE.[Methods] 45 patients with island-type or tongue-type SSBE were randomly divided into treatment group and control group.Treatment group was treated with APC combined with esomeprazole for 4 weeks,while the control group was treated with esomeprazole only.All patients were received the endoscopic review and biopsy at 3,6,9,and 12 months.If there was no effect on the patients of the treatment group,APC and esomeprazole was repeated.[Results] The treatment group's total effective rate was 100% and the average effective rate was 87.5%,while the control group's was 30.5%and 6.1%,the difference was statistically significant(P 0.01).All patients who received APC were no complications.[Conclusion] APC combined with esomeprazole using in SSBE is efficacy and safe,worthy of clinical promotion.
出处 《中国内镜杂志》 CSCD 北大核心 2012年第8期796-798,共3页 China Journal of Endoscopy
关键词 BARRETT食管 SSBE 舌形BE 岛形BE 氩离子凝固术 Barrett's esophagus short-segment Barrett's esophagus tongue-type island-type argon plasma coagulation
  • 相关文献

参考文献7

二级参考文献142

  • 1于中麟.Barrett食管内镜诊断进展[J].中华消化内镜杂志,2004,21(6):429-431. 被引量:25
  • 2Grund KE, Storek G, Farin G. Endoscopic argon plasma coagulation (APC) first clinic experiences in flexible endoscopy. Endosc Surg Allied Technol, 1994,2:42-46.
  • 3Watson JP, Bennett MK,Griffin SM, et al. The tissue effect of argon plasma coagulation on esophageal and gastric mucosa. Gastrointest Endosc, 2000,52: 342-345.
  • 4Gale P,Adeyemi B,Ferrer K,et al. Histologic characteristics of laparoscopic argon beam coagulation. J Am Assoc Gynecol Laparosc,1998,5:19-22.
  • 5Wahab PJ,Mulder CJ,den Hartog G,et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilotexperiences. Endoscopy,1997,29: 176-181.
  • 6Norton ID,Wang L, Levine SA,et al. In viwo characterization of colonic thermal injury caused by argon plasma coagulation. Gastrointest Ehdosc,2002,55:63l-636.
  • 7Oberg S,Wenner J, Johausson J, ctal. Barrett esophagus:risk factors for progression to dysplasia and adenocarcinoma. Ann Surg, 2005,242:49-54.
  • 8Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinnma in the United States. Cancer, 1998,83 : 2049-2053.
  • 9Eekardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Banett' s esophagus:a prospective controlled investigation. Am J Med ,2001,111:33-37.
  • 10Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol, 1998,93 : 1028-1032.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部